Skip to main content
Top
Published in: Abdominal Radiology 5/2010

01-10-2010

Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT

Authors: Patrick Veit-Haibach, Valerie Treyer, Klaus Strobel, Jan D. Soyka, Lars Husmann, Niklaus G. Schaefer, Alois Tschopp, Thomas F. Hany

Published in: Abdominal Radiology | Issue 5/2010

Login to get access

Abstract

Objective

To integrate CT-perfusion into a routine, clinical contrast-enhanced (ce) PET/CT protocol for the evaluation of liver metastases and to compare functional CT and PET parameters.

Materials and methods

Forty-six consecutive patients (mean age: 60 (34–82) years; 20 f, 26 m) with known liver lesions (colorectal metastases (n = 34), primary liver cancer (n = 4), breast cancer (n = 3), anal cancer, gastric cancer, esophageal cancer, GIST, duodenal cancer (all: n = 1) who were referred for staging or therapy follow-up by [18F]-Fluoro-2-deoxy-D-glucose-positron-emission-tomography/computed-tomography imaging (FDG-PET/CT) were included. After acquisition of a low-dose PET/CT, a split-injection (70–90 mL) ce-CT-protocol, including a 35-s CT-perfusion scan of the liver and a diagnostic ce-CT of the thorax and/or abdomen (70 s delay, iv-contrast volume: 90 mL, 4 mL/s) was performed. CT-perfusion parameters (BF, BV, MTT,) and semi-quantitative PET-parameters (SUVmax, SUVmean, TLG, PETvol) were analyzed and compared.

Results

CT-perfusion data could be obtained in all but one patient with shallow breathing. In all patients, diagnostic ce-PET/CT quality was adequate without the use of additional contrast media. Significant correlations (P < 0.05) were found for each of BF, BV, MTT, and SUVmax, further, BF and MTT correlated with TLG. Several other correlations were seen for other perfusion and PET-parameters.

Conclusion

Combined CT-perfusion/PET/CT-protocol without the use of additional contrast media is feasible and can be easily integrated in clinical routine. Perfusion parameters and PET-parameters are only partly correlating and therefore have to be investigated further at fixed time points during the course of disease and therapy.
Literature
1.
go back to reference Bellomi M, Petralia G, Sonzogni A, Zampino MG, Rocca A. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology. 2007;244:486–93CrossRefPubMed Bellomi M, Petralia G, Sonzogni A, Zampino MG, Rocca A. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology. 2007;244:486–93CrossRefPubMed
2.
go back to reference Miles KA, Griffiths MR, Keith CJ. Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging. 2006;33:22–8CrossRefPubMed Miles KA, Griffiths MR, Keith CJ. Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging. 2006;33:22–8CrossRefPubMed
3.
go back to reference Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue–initial experience. Radiology. 2007;243:736–43CrossRefPubMed Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue–initial experience. Radiology. 2007;243:736–43CrossRefPubMed
4.
go back to reference Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology. 2005;234:785–92CrossRefPubMed Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology. 2005;234:785–92CrossRefPubMed
5.
go back to reference Bisdas S, Spicer K, Rumboldt Z. Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging. Ajnr. 2008;29:1376–81CrossRefPubMed Bisdas S, Spicer K, Rumboldt Z. Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging. Ajnr. 2008;29:1376–81CrossRefPubMed
6.
go back to reference Groves AM, Wishart GC, Shastry M, et al. (2009) Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT. Eur J Nucl Med Mol Imaging 36(3):416–421CrossRefPubMed Groves AM, Wishart GC, Shastry M, et al. (2009) Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT. Eur J Nucl Med Mol Imaging 36(3):416–421CrossRefPubMed
7.
go back to reference Thomas JP, Arzoomanian RZ, Alberti D, et al. Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol. 2003;21:223–31CrossRefPubMed Thomas JP, Arzoomanian RZ, Alberti D, et al. Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol. 2003;21:223–31CrossRefPubMed
8.
go back to reference Wang JH, Min PQ, Wang PJ, et al. Dynamic CT Evaluation of Tumor Vascularity in Renal Cell Carcinoma. AJR Am J Roentgenol. 2006;186:1423–30CrossRefPubMed Wang JH, Min PQ, Wang PJ, et al. Dynamic CT Evaluation of Tumor Vascularity in Renal Cell Carcinoma. AJR Am J Roentgenol. 2006;186:1423–30CrossRefPubMed
9.
go back to reference Willett CG, Boucher Y, di Tomaso E, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nature medicine. 2004;10:145–7CrossRefPubMed Willett CG, Boucher Y, di Tomaso E, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nature medicine. 2004;10:145–7CrossRefPubMed
10.
go back to reference Yi CA, Lee KS, Kim EA, et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology. 2004;233:191–9CrossRefPubMed Yi CA, Lee KS, Kim EA, et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology. 2004;233:191–9CrossRefPubMed
11.
go back to reference Schoder H, Carlson DL, Kraus DH, et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med. 2006;47:755–62PubMed Schoder H, Carlson DL, Kraus DH, et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med. 2006;47:755–62PubMed
12.
go back to reference Schoder H, Larson SM, Yeung HW. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med. 2004;45 Suppl 1:72S-81SPubMed Schoder H, Larson SM, Yeung HW. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med. 2004;45 Suppl 1:72S-81SPubMed
13.
go back to reference Strobel K, Dummer R, Husarik DB, et al. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases. Radiology. 2007;244:566–74CrossRefPubMed Strobel K, Dummer R, Husarik DB, et al. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases. Radiology. 2007;244:566–74CrossRefPubMed
15.
go back to reference Veit-Haibach P, Kuehle, CA, Beyer, T, et al. (2006) Whole-body PET/CT-colonography: diagnostic accuracy of a new staging concept in patients with colorectal cancer. JAMA 296(21):2590–2600CrossRefPubMed Veit-Haibach P, Kuehle, CA, Beyer, T, et al. (2006) Whole-body PET/CT-colonography: diagnostic accuracy of a new staging concept in patients with colorectal cancer. JAMA 296(21):2590–2600CrossRefPubMed
16.
go back to reference Hillner BE, Siegel BA, Liu D, et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol. 2008;26:2155–61CrossRefPubMed Hillner BE, Siegel BA, Liu D, et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol. 2008;26:2155–61CrossRefPubMed
17.
go back to reference Goh V, Halligan S, Gharpuray A, et al. Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest. Radiology. 2008;247:726–32CrossRefPubMed Goh V, Halligan S, Gharpuray A, et al. Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest. Radiology. 2008;247:726–32CrossRefPubMed
18.
go back to reference Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ. Radiation dose to patients from cardiac diagnostic imaging. Circulation. 2007;116:1290–305CrossRefPubMed Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ. Radiation dose to patients from cardiac diagnostic imaging. Circulation. 2007;116:1290–305CrossRefPubMed
19.
go back to reference Kiessling F, Boese J, Corvinus C, Ederle JR, et al. Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring? Eur Radiol. 2004;14:1226–33PubMed Kiessling F, Boese J, Corvinus C, Ederle JR, et al. Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring? Eur Radiol. 2004;14:1226–33PubMed
20.
go back to reference Meijerink MR, van Cruijsen H, Hoekman K, et al. The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients. Eur Radiol. 2007;17:1700–13CrossRefPubMed Meijerink MR, van Cruijsen H, Hoekman K, et al. The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients. Eur Radiol. 2007;17:1700–13CrossRefPubMed
21.
go back to reference Meijerink MR, van Waesberghe JH, van der Weide L, et al. Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases. Eur Radiol. 2008;18:2345–54CrossRefPubMed Meijerink MR, van Waesberghe JH, van der Weide L, et al. Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases. Eur Radiol. 2008;18:2345–54CrossRefPubMed
22.
go back to reference Miles KA (2003) Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol 76(spec no 1):S36–S42 Miles KA (2003) Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol 76(spec no 1):S36–S42
23.
go back to reference Chung YE, Kim KW, Kim JH, et al. Optimal delay time for the hepatic parenchymal enhancement at the multidetector CT examination. Journal of computer assisted tomography. 2006;30:182–8CrossRefPubMed Chung YE, Kim KW, Kim JH, et al. Optimal delay time for the hepatic parenchymal enhancement at the multidetector CT examination. Journal of computer assisted tomography. 2006;30:182–8CrossRefPubMed
24.
go back to reference Groves AM, Wishart GC, Shastry M, et al. Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT. European journal of nuclear medicine and molecular imaging. 2009;36:416–21. doi:10.1007/s00259-008-0948-1 CrossRefPubMed Groves AM, Wishart GC, Shastry M, et al. Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT. European journal of nuclear medicine and molecular imaging. 2009;36:416–21. doi:10.​1007/​s00259-008-0948-1 CrossRefPubMed
25.
go back to reference Hermans R, Lambin P, Van der Goten A, et al. Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiother Oncol. 1999;53:105–11CrossRefPubMed Hermans R, Lambin P, Van der Goten A, et al. Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiother Oncol. 1999;53:105–11CrossRefPubMed
26.
go back to reference Kan Z, Phongkitkarun S, Kobayashi S, et al. Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model. Radiology. 2005;237:151–8CrossRefPubMed Kan Z, Phongkitkarun S, Kobayashi S, et al. Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model. Radiology. 2005;237:151–8CrossRefPubMed
27.
go back to reference Sabir A, Schor-Bardach R, Wilcox CJ, et al. Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy. AJR Am J Roentgenol. 2008;191:133–9CrossRefPubMed Sabir A, Schor-Bardach R, Wilcox CJ, et al. Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy. AJR Am J Roentgenol. 2008;191:133–9CrossRefPubMed
28.
go back to reference Akhurst T, Ng VV, Larson SM, et al. Tumor Burden Assessment with Positron Emission Tomography with. Clin Positron Imaging. 2000;3:57–65CrossRefPubMed Akhurst T, Ng VV, Larson SM, et al. Tumor Burden Assessment with Positron Emission Tomography with. Clin Positron Imaging. 2000;3:57–65CrossRefPubMed
29.
go back to reference Francis RJ, Byrne MJ, van der Schaaf AA, et al. Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. J Nucl Med. 2007;48:1449–58CrossRefPubMed Francis RJ, Byrne MJ, van der Schaaf AA, et al. Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. J Nucl Med. 2007;48:1449–58CrossRefPubMed
30.
go back to reference Steinert HC, Santos Dellea MM, Burger C, Stahel R. Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging. Lung Cancer. 2005;49 Suppl 1:S33–5CrossRefPubMed Steinert HC, Santos Dellea MM, Burger C, Stahel R. Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging. Lung Cancer. 2005;49 Suppl 1:S33–5CrossRefPubMed
Metadata
Title
Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT
Authors
Patrick Veit-Haibach
Valerie Treyer
Klaus Strobel
Jan D. Soyka
Lars Husmann
Niklaus G. Schaefer
Alois Tschopp
Thomas F. Hany
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 5/2010
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-009-9559-y

Other articles of this Issue 5/2010

Abdominal Radiology 5/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine